Peptide record

TPDB92537

iRGD Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92537
iRGD
Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 9-aa modified multi-activity (Anticancer, Blood-Brain Barrier, Cell-penetrating Peptides, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
N-terminal: TP5
Sequence
CRGDRGPDC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
CendR Activity
TP5 Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Homing
Alpha 5 Beta 3 integrins

Source & Reference

TumorHoPe2.0
TumorHoPe2
Increased antitumor activity of tumor-specific peptide modified thymopentin
2014
Lao X et al. Biochimie.2014 Dec:107 Pt B:277-85

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Mouse melanoma cell line B16F10, Human breast cancer cell line MCF-7, Human lung cancer cell line H460
C57BL/6 mice
Phage Display Library
TP5 at n-terminus
Additional Detail Fields 3 fields
TP5 at n-terminus
Mouse melanoma cell line B16F10, Human breast cancer cell line MCF-7, Human lung cancer cell line H460
C57BL/6 mice